{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T09:14:12Z","timestamp":1794129252878,"version":"4.8.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cgh.2024.08.032","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T12:16:15Z","timestamp":1727180175000},"page":"1019-1029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Efficacy and Safety of Upadacitinib for Perianal Fistulizing Crohn\u2019s Disease: A Post Hoc Analysis of 3 Phase 3 Trials"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6472-249X","authenticated-orcid":false,"given":"Jean-Fr\u00e9d\u00e9ric","family":"Colombel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana P.","family":"Lacerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Irving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remo","family":"Panaccione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Reinisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Rieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Steinlauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Dubcenco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel I.","family":"Anyanwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Stephen","family":"Laroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colla","family":"Cunneen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2024.08.032_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpsurg.2020.100808","article-title":"Fistulizing Crohn's disease","volume":"57","author":"Lightner","year":"2020","journal-title":"Curr Probl Surg"},{"key":"10.1016\/j.cgh.2024.08.032_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ibd\/izy247","article-title":"Clinical practice guideline for the medical management of perianal fistulizing Crohn's disease: the Toronto consensus","volume":"25","author":"Steinhart","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.08.032_bib3","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/ibd\/izab287","article-title":"Epidemiology and natural history of perianal Crohn's disease: a systematic review and meta-analysis of population-based cohorts","volume":"28","author":"Tsai","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.08.032_bib4","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/ecco-jcc\/jjad008","article-title":"Pathogenesis of perianal fistulising Crohn\u2019s disease: current knowledge, gaps in understanding, and future research directions","volume":"17","author":"Cao","year":"2023","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.08.032_bib5","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/gast.2002.32362","article-title":"The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota","volume":"122","author":"Schwartz","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.08.032_bib6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-0039-1687834","article-title":"Perianal Crohn's disease","volume":"32","author":"Pogacnik","year":"2019","journal-title":"Clin Colon Rectal Surg"},{"key":"10.1016\/j.cgh.2024.08.032_bib7","first-page":"470","article-title":"Perianal fistulas in patients with Crohn's disease, part 1: current medical management","volume":"14","author":"Gold","year":"2018","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.cgh.2024.08.032_bib8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/s12955-020-01622-7","article-title":"Burden of disease and adaptation to life in patients with Crohn's perianal fistula: a qualitative exploration","volume":"18","author":"Adegbola","year":"2020","journal-title":"Health Qual Life Outcomes"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2024.08.032_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000506364","article-title":"Treatment algorithms for Crohn's disease","volume":"101","author":"Sulz","year":"2020","journal-title":"Digestion"},{"key":"10.1016\/j.cgh.2024.08.032_bib10","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1053\/j.gastro.2021.04.022","article-title":"AGA clinical practice guidelines on the medical management of moderate to severe luminal and perianal fistulizing Crohn's disease","volume":"160","author":"Feuerstein","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.08.032_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/ecco-jcc\/jjz187","article-title":"ECCO guidelines on therapeutics in Crohn's disease: surgical treatment","volume":"14","author":"Adamina","year":"2020","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.08.032_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3393\/ac.2021.02.08","article-title":"Treatment strategy for perianal fistulas in Crohn disease patients: the surgeon's point of view","volume":"37","author":"Lee","year":"2021","journal-title":"Ann Coloproctol"},{"key":"10.1016\/j.cgh.2024.08.032_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/00365521.2020.1854848","article-title":"Efficacy of ustekinumab for active perianal fistulizing Crohn's disease: a systematic review and meta-analysis of the current literature","volume":"56","author":"Attauabi","year":"2021","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.08.032_bib14","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.14309\/ajg.0000000000000810","article-title":"Ustekinumab for perianal Crohn's disease: the BioLAP multicenter study from the GETAID","volume":"115","author":"Chapuis-Biron","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.08.032_bib15","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/apt.15665","article-title":"Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients","volume":"51","author":"Chapuis-Biron","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.08.032_bib16","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cgh.2021.09.028","article-title":"Efficacy and safety of 2 vedolizumab intravenous regimens for perianal fistulizing Crohn's disease: ENTERPRISE study","volume":"20","author":"Schwartz","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.08.032_bib17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/DCR.0000000000002325","article-title":"Follow-up study to evaluate the long-term safety and efficacy of darvadstrocel (mesenchymal stem cell treatment) in patients with perianal fistulizing Crohn's disease: ADMIRE-CD phase 3 randomized controlled trial","volume":"65","author":"Garcia-Olmo","year":"2022","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cgh.2024.08.032_bib18","doi-asserted-by":"crossref","unstructured":"Serclova Z, Garcia-Olmo D, Chen ST, et\u00a0al. Efficacy and safety of darvadstrocel treatment in patients with complex perianal fistulas and Crohn\u2019s disease: results from the global ADMIRE-CD II phase 3 study. J Crohns Colitis;18:i34-i35.","DOI":"10.1093\/ecco-jcc\/jjad212.0018"},{"key":"10.1016\/j.cgh.2024.08.032_bib19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ecco-jcc\/jjac144","article-title":"Darvadstrocel for complex perianal fistulas in Japanese adults with Crohn's disease: a phase 3 study","volume":"17","author":"Furukawa","year":"2023","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.08.032_bib20","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/gutjnl-2017-314918","article-title":"Modern management of perianal fistulas in Crohn's disease: future directions","volume":"67","author":"Kotze","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.08.032_bib21","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S2468-1253(22)00007-3","article-title":"Classifying perianal fistulising Crohn's disease: an expert consensus to guide decision-making in daily practice and clinical trials","volume":"7","author":"Geldof","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.08.032_bib22","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/MIB.0000000000000705","article-title":"Perianal Crohn's disease is associated with distal colonic disease, stricturing disease behavior, IBD-associated serologies and genetic variation in the JAK-STAT pathway","volume":"22","author":"Kaur","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.08.032_bib23","doi-asserted-by":"crossref","first-page":"i019","DOI":"10.1093\/ecco-jcc\/jjab232.017","article-title":"OP18 Efficacy and safety of filgotinib for the treatment of perianal fistulizing Crohn\u2019s disease: results from the phase 2 DIVERGENCE 2 study","volume":"16","author":"Reinisch","year":"2022","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.08.032_bib26","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1056\/NEJMoa2212728","article-title":"Upadacitinib induction and maintenance therapy for Crohn\u2019s disease","volume":"388","author":"Loftus","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2024.08.032_bib27","article-title":"The impact of Crohn's perianal fistula on quality of life: results of an international patient survey","volume":"5","author":"Spinelli","year":"2023","journal-title":"Crohns Colitis 360"},{"key":"10.1016\/j.cgh.2024.08.032_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(17)30930-7","article-title":"Fistula healing in pivotal studies of ustekinumab in Crohn's disease","volume":"152","author":"Sands","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.08.032_bib29","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/ecco-jcc\/jjae003","article-title":"Efficacy and safety of filgotinib for the treatment of perianal fistulizing Crohn's disease [DIVERGENCE 2]: a phase 2, randomized, placebo-controlled trial","volume":"18","author":"Reinisch","year":"2024","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.08.032_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/jgh.16358","article-title":"Efficacy and safety of risankizumab for Crohn's disease in patients from Asian countries: a post hoc subanalysis of the global phase 3 ADVANCE, MOTIVATE, and FORTIFY studies","volume":"39","author":"Gao","year":"2024","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.08.032_bib31","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/ibd\/izz200","article-title":"Pedictors of perianal fistula relapse in Crohn's disease","volume":"26","author":"Malian","year":"2020","journal-title":"Inflamm Bowel Dis"}],"updated-by":[{"DOI":"10.1016\/j.cgh.2025.07.005","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000}}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524008607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524008607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:25:16Z","timestamp":1758126316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356524008607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1542356524008607"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2024.08.032","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Upadacitinib for Perianal Fistulizing Crohn\u2019s Disease: A Post Hoc Analysis of 3 Phase 3 Trials","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2024.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}